Clinical Trial Update: Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan [Phase 4]

View source ↗

Summary

This Phase 4 trial examined whether low sodium intake enhances the anti-proteinuric effects of olmesartan in patients with hypertension and chronic kidney disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension
• Microalbuminuria

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Hypertension, Chronic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-12-18